MSInsight is a start-up based on academic research at the interface of oncology, genomics (genome study) and bioinformatics (computer science applied to life sciences). Our company aims to revolutionize the management of a common category of cancers, MSI cancers. This MSI characteristic is frequently observed in gynecological and digestive cancers, its detection is of increasing interest for all cancers.
MSInsight aims to provide hospitals and medical laboratories with a powerful solution to identify the error rate in the genetic code responsible for the disease.
Technology solutions work to give oncologists simple tools to help them to make the best treatment decisions for their patients to achieve precision medicine.
